Olema Pharmaceuticals Earnings Estimate

OLMA Stock  USD 25.01  1.33  5.05%   
By analyzing Olema Pharmaceuticals' earnings estimates, investors can diagnose different trends across Olema Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Olema Pharmaceuticals is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Olema Pharmaceuticals is projected to generate -0.57765 in earnings per share on the 31st of December 2026. Olema Pharmaceuticals earnings estimates show analyst consensus about projected Olema Pharmaceuticals EPS (Earning Per Share). It derives the highest and the lowest estimates based on Olema Pharmaceuticals' historical volatility. Many public companies, such as Olema Pharmaceuticals, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Olema Pharmaceuticals' earnings estimates, investors can diagnose different trends across Olema Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. As of February 6, 2026, Gross Profit is expected to decline to about (371.4 K)Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Olema Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.

Olema Pharmaceuticals Earnings per Share Projection vs Actual

About Olema Pharmaceuticals Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Olema Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Olema Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Olema Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-391.6 M-372 M
Retained Earnings Total Equity-188.1 M-197.5 M
Earnings Yield(0.43)(0.46)
Price Earnings Ratio(2.38)(2.50)
Price Earnings To Growth Ratio(1.08)(1.03)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Olema Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Olema Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Olema Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Olema Pharmaceuticals Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Olema Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.
For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. Anticipated expansion of Olema directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Olema Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.77)
Return On Assets
(0.34)
Return On Equity
(0.59)
Olema Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Olema's balance sheet. Smart investors calculate Olema Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Olema Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Olema Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Olema Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.